Evidence map›Paper›PMID 19864409›Full record

Trial reportThe American journal of clinical nutrition2009

A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.

Kana Wu, Elizabeth A Platz, Walter C Willett, Charles S Fuchs, Jacob Selhub, Bernard A Rosner, David J Hunter, Edward Giovannucci

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00512850 (The Nurses' Health Study), which is not on this map. Cited by 48 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 10 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00512850 nacompletednot on this map

The Nurses' Health Study (NHS) and Health Professionals Follow-Up Study (HPFS) Folic Acid Prevention Trial

TypeinterventionalSponsorBrigham and Women's HospitalRan1996 to 2017Enrolled672ConditionsAdenoma of Large IntestineArmsFolic acid, Placebo
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 10 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Meta-analysis: eating frequency and risk of colorectal cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Scientific opinion on the tolerable upper intake level for folate.EFSA journal. European Food Safety Authority · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kana WuDepartment of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA. kana.wu@channing.harvard.edu
Elizabeth A Platz
Walter C Willett
Charles S Fuchs
Jacob Selhub
Bernard A Rosner
David J Hunter
Edward Giovannucci
Harvard University · US

Funding

Dietary Patterns, Diet Quality + Cancer RiskR01CA095589 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI HU, FRANK B · 2003 to 2012
$2.7M
RANDOMIZED TRIAL OF FOLATE AND COLORECTAL ADENOMAR01CA067883 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIOVANNUCCI, EDWARD · 1995 to 2003
$889k
NCI NIH HHS CA 55075NCI NIH HHS CA95589NCI NIH HHS R01 CA067883NCI NIH HHS R01 CA 67883PHS HHS U54 100971
6 · The paper itself

Abstract

backgroundEvidence from observational studies suggests that inadequate folate status enhances colorectal carcinogenesis, but results from some randomized trials do not support this hypothesis.

objectiveTo assess the effect of folic acid supplementation on recurrent colorectal adenoma, we conducted a cost-efficient, double-blind, randomized trial among participants of 2 large prospective cohorts, the Health Professionals Follow-Up Study and the Nurses' Health Study.

designParticipants were randomly assigned to receive folic acid (1 mg/d) (n = 338) or placebo (n = 334) for 3-6.5 y. The primary endpoint was any new diagnosis of adenoma during the study period (May 1996-March 2004). Secondary outcomes were adenoma by site and stage and number of recurrent adenomas. Associations were also examined by plasma folate concentrations at baseline.

resultsIncidence of at least one recurrent adenoma was not significantly associated with folic acid supplementation [relative risk (RR): 0.82; 95% CI: 0.59,1.13; P = 0.22]. Among participants with low plasma folate concentrations at baseline (<or=7.5 ng/mL), those randomly assigned to receive folic acid experienced a significant decrease in adenoma recurrence (RR: 0.61; 95% CI: 0.42, 0.90; P = 0.01), whereas for subjects with high folate concentrations at baseline (>7.5 ng/mL), supplemental folic acid had no significant effect (RR: 1.28; 95% CI: 0.82, 1.99; P = 0.27, P(interaction) = 0.01). Contrary to findings from another clinical trial, there was no evidence for an increased risk of advanced or multiple adenomas.

conclusionsOur results do not support an overall protective effect of folic acid supplementation on adenoma recurrence. Folic acid supplementation may be beneficial among those with lower folate concentrations at baseline. This trial was registered at clinical trials.gov as NCT00512850.

Indexed as

Dietary SupplementsAdenomaAgedColorectal NeoplasmsDouble-Blind MethodFemaleFolic AcidHumansMaleMiddle AgedNeoplasm Recurrence, LocalProspective StudiesFolic Acid

Identifiers

PMID19864409
PMCPMC2777472
OpenAlexW2151107273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.